Workshops and Exchange Groups for Laryngectomized Patients
Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Oct 5, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on helping people who have had their voice box (larynx) removed due to laryngeal cancer. The aim is to improve their quality of life by providing workshops and support groups where they can share experiences and learn from each other. This trial is particularly important because laryngeal cancer affects many people, and the removal of the larynx can significantly change how they communicate and live their daily lives.
To participate in this trial, individuals must be over 18 years old and have had a total laryngectomy at Bichat Hospital or HEGP within the last four years. They should have finished their medical treatments related to their cancer and be able to attend all four scheduled sessions at the hospital. Participants will have the opportunity to connect with others in similar situations, learn new coping strategies, and receive support to enhance their overall well-being. It’s also important to note that this trial is currently recruiting participants.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Have had a total laryngectomy at Bichat Hospital or HEGP within the last four years
- • Have completed all the specific care of the pathology that required the total laryngectomy
- • Be able to travel to Bichat Hospital for all four sessions
- • Be over 18 years of age
- • Have received informed information about the conduct of the research.
- Exclusion Criteria:
- • WHO simplified autonomy scale greater than 2, i.e. from normal activity to ambulant and able to take care of themselves, but unable to provide work and bedridden for less than 50% of their time
- • Patient who does not speak or understand French
- • Lack of affiliation to a social security scheme or CMU
- • Patient benefiting from legal protection measures (guardianship or curatorship)
- • Patient who has communicated an objection to their inclusion, after informed information.
About Assistance Publique Hôpitaux De Paris
Assistance Publique - Hôpitaux de Paris (AP-HP) is a leading public hospital system in France, renowned for its commitment to healthcare excellence and innovative medical research. As a prominent clinical trial sponsor, AP-HP plays a pivotal role in advancing medical knowledge and improving patient care through rigorous scientific investigations across a wide range of therapeutic areas. With a focus on collaboration and interdisciplinary approaches, AP-HP leverages its extensive network of hospitals and expert clinicians to facilitate high-quality clinical trials that adhere to the highest ethical and regulatory standards, ultimately aiming to translate research findings into tangible health benefits for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Paris, , France
Patients applied
Trial Officials
Angèle Germon
Principal Investigator
Assistance Publique - Hôpitaux de Paris
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported